Ferring Inc. v. Canada (Minister of Health) et al., (2007) 310 F.T.R. 185 (FC)

This document cites

• Aventis Pharma Inc. v. Apotex Inc. et al., (2005) 278 F.T.R. 1 (FC)
• Aventis Pharma Inc. v. Canada (Minister of Health) et al., [2005] F.T.R. Uned. A93
• Apotex Inc. et al. v. Canada (Minister of National Health and Welfare) et al., (1999) 252 N.R. 72 (FCA)
• Bristol-Myers Squibb Co. et al. v. Canada (Attorney General) et al., (2005) 334 N.R. 55 (SCC)
• Merck & Co. v. Brantford Chemicals Inc., 2005 FCA 48



See all quotations

• Bayer Inc. v. Can. (A.G.), (1999) 243 N.R. 170 (FCA)
• Merck Frosst Canada Inc. et al. v. Canada (Minister of National Health and Welfare) et al., (1998) 227 N.R. 299 (SCC)
• Monsanto Co. et al. v. Commissioner of Patents et al., (1999) 172 F.T.R. 210 (TD)
• Schering Canada Inc. et al. v. Nu-Pharm Inc. et al., (1996) 114 F.T.R. 310 (TD)
• Apotex Inc. v. Governor-in-Council et al., 2007 FC 232
• Rothmans of Pall Mall Canada Ltd. and Imperial Tobacco Ltd. v. Minister of National Revenue et al., (1976) 10 N.R. 153 (FCA)
• Aventis Pharma Inc. v. Apotex Inc. et al., 2006 FCA 64
• AstraZeneca Canada Inc. v. Canada (Minister of Health) et al., (2004) 259 F.T.R. 294 (FC)
• Laboratoires Servier et al. v. Apotex Inc. et al., [2007] F.T.R. Uned. 9
• Chandler v. Alberta Association of Architects, (1989) 99 N.R. 277 (SCC)
• AstraZeneca Canada Inc. v. Canada (Minister of Health) et al., 2005 FCA 58
• Comeau's Sea Foods Ltd. v. Canada (Minister of Fisheries and Oceans), (1997) 206 N.R. 363 (SCC)
• Baker v. Can. (M.C.I.), (1999) 243 N.R. 22 (SCC)
• Hoffmann-La Roche Ltd. et al. v. Canada (Minister of National Health and Welfare) et al., (1999) 167 F.T.R. 111 (TD)
• AstraZeneca Canada Inc. v. Canada (Minister of Health) et al., (2006) 354 N.R. 88 (SCC)
• Apotex Inc. v. Merck & Co. and Merck Frosst Canada Inc., (1993) 162 N.R. 177 (FCA)
• Saskatchewan Wheat Pool v. Canadian Grain Commission, (2004) 260 F.T.R. 310 (FC)
• Novopharm Ltd. v. Canada (Minister of National Health and Welfare) et al., (1998) 149 F.T.R. 63 (TD)
• Warner-Lambert Canada Inc. et al. v. Canada (Minister of Health), (2000) 193 F.T.R. 117 (TD)
• AstraZeneca Canada Inc. v. Canada (Minister of Health), [2006] 2 SCR 560
• Decision of the EEA Joint Committee No 6/2006 of 27 January 2006 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement
• 2006/8/EC: Commission Decision of 4 January 2006 amending Decision 92/452/EEC as regards certain embryo collection and production teams in Canada and the United States of America (notified under document number C(2005) 5795) (Text with EEA relevance)
• Decision of the EEA Joint Committee No 22/2004 of 19 March 2004 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement
• 2006/12/EC: Decision of the European Parliament and of the Council of 17 November 2005 on the mobilisation of the European Union Solidarity Fund according to point 3 of the Interinstitutional Agreement of 7 November 2002 between the European Parliament, the Council and the Commission on the financing of the European Union Solidarity Fund supplementing the Interinstitutional Agreement of 6 May 1999 on budgetary discipline and improvement of the budgetary procedure
• 96/23/EC: Commission Decision of 20 December 1995 laying down the rules for technical and scientific measures concerning the control of classical swine fever and the financial contribution from the Community (Text with EEA relevance) (Only the French and Dutch texts are authentic)